Home › Free Stock Grades › RDNT
RadNet, Inc. (RDNT) Stock Grade
RDNT · Healthcare
B-
Market Cap
$5.6B
P/E Ratio
—
Revenue Growth (YoY)
+11.5%
Net Margin
-0.9%
Return on Equity
—
Dividend Yield
None
About RadNet, Inc.'s fundamentals
RadNet is a medical diagnostics company with a market capitalization of $5.6 billion that grew revenue by 11.5% year-over-year. Despite the revenue growth, the company reported a net loss with a negative net margin of -0.9% in its latest annual statement. However, the company generated positive free cash flow despite its accounting losses, suggesting operational cash generation independent of profitability metrics. Traditional valuation metrics like P/E ratio and return on equity are not available due to the company's unprofitable status.